Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Generated: May 29, 2017

DrugPatentWatch Database Preview

Epinephrine - Generic Drug Details

« Back to Dashboard

What are the generic drug sources for epinephrine and what is the scope of epinephrine freedom to operate?

is the generic ingredient in thirty-one branded drugs marketed by Par Sterile Products, Amedra Pharms, Sterling, Armstrong Pharms, Wyeth Cons, Belcher Pharms Llc, Mylan Speciality Lp, Kaleo Inc, Forest Labs, 3M, Astrazeneca, Dentsply Pharm, Deproco, Septodont Inc, Intl Medication, Belmora Llc, Vyteris, West-ward Pharms Int, Carlisle, Bel Mar, Pharmaton, Iomed, Hospira, Septodont, Abbott, Eastman Kodak, Watson Labs, Empi, Fresenius Kabi Usa, and Dell Labs, and is included in fifty-one NDAs. There are thirty-three patents protecting this compound and three Paragraph IV challenges. Additional information is available in the individual branded drug profile pages.

Epinephrine has one hundred and sixty-nine patent family members in twenty-five countries.

There are nineteen drug master file entries for epinephrine. Seventeen suppliers are listed for this compound.

Summary for Generic Name: epinephrine

Drug Master File Entries: see list19
Suppliers / Packagers: see list17
Bulk Api Vendors: see list54
Clinical Trials: see list181
Patent Applications: see list7,862
Therapeutic Class:Respiratory Tract Agents
Formulation / Manufacturing:see details
Drug Prices:see low prices
DailyMed Link:epinephrine at DailyMed

Pharmacology for Ingredient: epinephrine

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Dell Labs
epinephrine; lidocaine hydrochloride
INJECTABLE;INJECTION083389-001Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe
Mylan Speciality Lp
INJECTABLE;INTRAMUSCULAR019430-004Aug 3, 1995DISCNNoNo► Subscribe► Subscribe
epinephrine; lidocaine hydrochloride
INJECTABLE;INJECTION084728-001Aug 17, 1983DISCNNoNo► Subscribe► Subscribe
Kaleo Inc
INJECTABLE;INTRAMUSCULAR, SUBCUTANEOUS201739-002Aug 10, 2012BXRXYesYes8,926,594► SubscribeY ► Subscribe
AEROSOL, METERED;INHALATION016803-001Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Subscribe for Complete Access

  • Find generic sources and suppliers
  • Formulary management
  • Uncover prior art in abandoned patent applications and expired patents

► Plans and Pricing

Expired Orange Book Patents

 Available with subscription

Paragraph IV Activity

 Available with subscription

Patent Maintenance

 Available with subscription

Non-Orange Book Patents

 Available with subscription

International Patents

 Available with subscription

Supplementary Protection Certificates

 Available with subscription

« Back to the Dashboard

For more information try a trial or see the database preview and plans and pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted

Follow DrugPatentWatch:

Google Plus